If you made any changes in Pure these will be visible here soon.

Research Output

2013

From trial highlights to clinical context: Putting American Society of Clinical Oncology gastrointestinal news into practice

Aprile, G., Lutrino, S. E. & Sobrero, A., May 2013, In : Future Oncology. 9, 5, p. 645-648 4 p.

Research output: Contribution to journalArticle

Regorafenib monotherapy for previously treated metastatic colorectal cancer (CORRECT): An international, multicentre, randomised, placebo-controlled, phase 3 trial

Grothey, A., Van Cutsem, E., Sobrero, A., Siena, S., Falcone, A., Ychou, M., Humblet, Y., Bouché, O., Mineur, L., Barone, C., Adenis, A., Tabernero, J., Yoshino, T., Lenz, H. J., Goldberg, R. M., Sargent, D. J., Cihon, F., Cupit, L., Wagner, A. & Laurent, D., Jan 2013, In : Lancet. 381, 9863, p. 303-312 10 p.

Research output: Contribution to journalArticle

Sorafenib in combination with oxaliplatin, leucovorin, and fluorouracil (modified FOLFOX6) as first-line treatment of metastatic colorectal cancer: The RESPECT trial

Tabernero, J., Garcia-Carbonero, R., Cassidy, J., Sobrero, A., Van Cutsem, E., Köhne, C. H., Tejpar, S., Gladkov, O., Davidenko, I., Salazar, R., Vladimirova, L., Cheporov, S., Burdaeva, O., Rivera, F., Samuel, L., Bulavina, I., Potter, V., Chang, Y. L., Lokker, N. A. & O'Dwyer, P. J., May 1 2013, In : Clinical Cancer Research. 19, 9, p. 2541-2550 10 p.

Research output: Contribution to journalArticle

The IDEA (international duration evaluation of adjuvant chemotherapy) collaboration: Prospective combined analysis of phase III trials investigating duration of adjuvant therapy with the FOLFOX (FOLFOX4 or modified FOLFOX6) or XELOX (3 versus 6 months) regimen for patients with stage III colon cancer: Trial design and current status

André, T., Iveson, T., Labianca, R., Meyerhardt, J. A., Souglakos, I., Yoshino, T., Paul, J., Sobrero, A., Taieb, J., Shields, A. F., Ohtsu, A., Grothey, A. & Sargent, D. J., Sep 2013, In : Current Colorectal Cancer Reports. 9, 3, p. 261-269 9 p.

Research output: Contribution to journalArticle

What is the Best Sequence of Targeted Agents in the Management of Advanced Colorectal Cancer

Sobrero, A. & Alessandro, P., Nov 2013, In : Annals of Oncology. 24, p. ix8

Research output: Contribution to journalArticle

Open Access
2012

Cediranib with mFOLFOX6 versus bevacizumab with mFOLFOX6 as first-line treatment for patients with advanced colorectal cancer: A double-blind, randomized phase III study (HORIZON III)

Schmoll, H. J., Cunningham, D., Sobrero, A., Karapetis, C. S., Rougier, P., Koski, S. L., Kocakova, I., Bondarenko, I., Bodoky, G., Mainwaring, P., Salazar, R., Barker, P., Mookerjee, B., Robertson, J. & Van Cutsem, E., Oct 10 2012, In : Journal of Clinical Oncology. 30, 29, p. 3588-3595 8 p.

Research output: Contribution to journalArticle

Esmo consensus guidelines for management of patients with colon and rectal cancer. A personalized approach to clinical decision making

Schmoll, H. J., Van cutsem, E., Stein, A., Valentini, V., Glimelius, B., Haustermans, K., Nordlinger, B., Van de Velde, C. J., Balmana, J., Regula, J., Nagtegaal, I. D., Beets-Tan, R. G., Arnold, D., Ciardiello, F., Hoff, P., Kerr, D., Köhne, C. H., Labianca, R., Price, T., Scheithauer, W. & 17 others, Sobrero, A., Tabernero, J., Aderka, D., Barroso, S., Bodoky, G., Douillard, J. Y., El ghazaly, H., Gallardo, J., Garin, A., Glynne-jones, R., Jordan, K., Meshcheryakov, A., Papamichail, D., Pfeiffer, P., Souglakos, I., Turhal, S. & Cervantes, A., Oct 2012, In : Annals of Oncology. 23, 10, p. 2479-2516 38 p., mds236.

Research output: Contribution to journalArticle

TAS-102 in refractory colorectal cancer: Caution is needed

Sobrero, A., Oct 2012, In : The Lancet Oncology. 13, 10, p. 959-961 3 p.

Research output: Contribution to journalArticle

The need for a new fluoropyrimidine in advanced gastric cancer treatment

Van Cutsem, E., Haller, D. G., Sobrero, A., Yamada, Y., Douillard, J. Y. & Moehler, M., Nov 2012, In : European Oncology and Haematology. 8, 4, p. 232-240 9 p.

Research output: Contribution to journalArticle

The oncosurgery approach to managing liver metastases from colorectal cancer: A multidisciplinary international consensus

Adam, R., De Gramont, A., Figueras, J., Guthrie, A., Kokudo, N., Kunstlinger, F., Loyer, E., Poston, G., Rougier, P., Rubbia-Brandt, L., Sobrero, A., Tabernero, J., Teh, C., Van Cutsem, E. & Vauthey, J. N., 2012, In : The oncologist. 17, 10, p. 1225-1239 15 p.

Research output: Contribution to journalArticle

2011

Intermittent versus continuous chemotherapy in advanced colorectal cancer: A randomised 'GISCAD' trial

Labianca, R., Sobrero, A., Isa, L., Cortesi, E., Barni, S., Nicolella, D., Aglietta, M., Lonardi, S., Corsi, D., Turci, D., Beretta, G. D., Fornarini, G., Dapretto, E., Floriani, I. & Zaniboni, A., 2011, In : Annals of Oncology. 22, 5, p. 1236-1242 7 p.

Research output: Contribution to journalArticle

Pancreatic cancer treatment and research: An international expert panel discussion

Tempero, M. A., Berlin, J., Ducreux, M., Haller, D., Harper, P., Khayat, D., Schmoll, H. J., Sobrero, A. & van Cutsem, E., 2011, In : Annals of Oncology. 22, 7, p. 1500-1506 7 p.

Research output: Contribution to journalArticle

Phase II study of sunitinib as second-line treatment for advanced gastric cancer

Bang, Y. J., Kang, Y. K., Kang, W. K., Boku, N., Chung, H. C., Chen, J. S., Doi, T., Sun, Y., Shen, L., Qin, S., Ng, W. T., Tursi, J. M., Lechuga, M. J., Lu, D. R., Ruiz-Garcia, A. & Sobrero, A., Dec 2011, In : Investigational New Drugs. 29, 6, p. 1449-1458 10 p.

Research output: Contribution to journalArticle

The diagnosis and management of gastric cancer: Expert discussion and recommendations from the 12th ESMO/World Congress on Gastrointestinal Cancer, Barcelona, 2010

van Cutsem, E., Dicato, M., Geva, R., Arber, N., Bang, Y., Benson, A., Cervantes, A., Diaz-Rubio, E., Ducreux, M., Glynne-Jones, R., Grothey, A., Haller, D., Haustermans, K., Kerr, D., Nordlinger, B., Marshall, J., Minsky, B. D., Kang, Y. K., Labianca, R., Lordick, F. & 9 others, Ohtsu, A., Pavlidis, N., Roth, A., Rougier, P., Schmoll, H. J., Sobrero, A., Tabernero, J., van de Velde, C. & Zalcberg, J., 2011, In : Annals of Oncology. 22, SUPPL. 5

Research output: Contribution to journalArticle

Two doses of NGR-hTNF in combination with capecitabine plus oxaliplatin in colorectal cancer patients failing standard therapies

Mammoliti, S., Andretta, V., Bennicelli, E., Caprioni, F., Comandini, D., Fornarini, G., Guglielmi, A., Pessino, A., Sciallero, S., Sobrero, A. F., Mazzola, G., Lambiase, A. & Bordignon, C., 2011, In : Annals of Oncology. 22, 4, p. 973-978 6 p.

Research output: Contribution to journalArticle

Vatalanib in advanced colorectal cancer: Two studies with identical results

Sobrero, A. F. & Bruzzi, P., May 20 2011, In : Journal of Clinical Oncology. 29, 15, p. 1938-1940 3 p.

Research output: Contribution to journalArticle

2010

Chemotherapy: Which drug and when?

Sobrero, A. & Bennicelli, E., Oct 2010, In : Annals of Oncology. 21, SUPPL. 7

Research output: Contribution to journalArticle

Current opinion on optimal treatment choices in first-line therapy for advanced or metastatic colorectal cancer: Report from the adelaide colorectal tumour group meeting; Stockholm, Sweden; September 2008

Price, T. J., Tebbutt, N. C., Karapetis, C. S., Segelov, E., Pavlakis, N., Cunningham, D., Sobrero, A. F., Haller, D. G. & Shapiro, J. D., Jan 1 2010, In : Clinical Colorectal Cancer. 9, 1, p. 8-14 7 p.

Research output: Contribution to journalArticle

Molecular markers and biological targeted therapies in metastatic colorectal cancer: expert opinion and recommendations derived from the 11th ESMO/World Congress on Gastrointestinal Cancer, Barcelona, 2009.

Van Cutsem, E., Dicato, M., Arber, N., Berlin, J., Cervantes, A., Ciardiello, F., De Gramont, A., Diaz-Rubio, E., Ducreux, M., Geva, R., Glimelius, B., Glynne Jones, R., Grothey, A., Gruenberger, T., Haller, D., Haustermans, K., Labianca, R., Lenz, H. J., Minsky, B., Nordlinger, B. & 8 others, Ohtsu, A., Pavlidis, N., Rougier, P., Schmiegel, W., Van de Velde, C., Schmoll, H. J., Sobrero, A. & Tabernero, J., Jun 2010, In : Annals of Oncology. 21 Suppl 6

Research output: Contribution to journalArticle

Phase II study of NGR-hTNF, a selective vascular targeting agent, in patients with metastatic colorectal cancer after failure of standard therapy

Santoro, A., Rimassa, L., Sobrero, A. F., Citterio, G., Sclafani, F., Carnaghi, C., Pessino, A., Caprioni, F., Andretta, V., Tronconi, M. C., Finocchiaro, G., Rossoni, G., Zanoni, A., Miggiano, C., Rizzardi, G. P., Traversari, C., Caligaris-Cappio, F., Lambiase, A. & Bordignon, C., Oct 2010, In : European Journal of Cancer. 46, 15, p. 2746-2752 7 p.

Research output: Contribution to journalArticle

Randomized phase III study of panitumumab with fluorouracil, leucovorin, and irinotecan (FOLFIRI) compared with FOLFIRI alone as second-line treatment in patients with metastatic colorectal cancer

Peeters, M., Price, T. J., Cervantes, A., Sobrero, A. F., Ducreux, M., Hotko, Y., André, T., Chan, E., Lordick, F., Punt, C. J. A., Strickland, A. H., Wilson, G., Ciuleanu, T. E., Roman, L., Van Cutsem, E., Tzekova, V., Collins, S., Oliner, K. S., Rong, A. & Gansert, J., Nov 1 2010, In : Journal of Clinical Oncology. 28, 31, p. 4706-4713 8 p.

Research output: Contribution to journalArticle

Reply to M.L. Berger et al

Sobrero, A. & Bruzzi, P., Jul 10 2010, In : Journal of Clinical Oncology. 28, 20

Research output: Contribution to journalArticle

2009

Association of progression-free survival, overall survival, and patient-reported outcomes by skin toxicity and KRAS status in patients receiving panitumumab monotherapy

Peeters, M., Siena, S., Van Cutsem, E., Sobrero, A., Hendlisz, A., Cascinu, S., Kalofonos, H., Devercelli, G., Wolf, M. & Amado, R. G., Apr 1 2009, In : Cancer. 115, 7, p. 1544-1554 11 p.

Research output: Contribution to journalArticle

Combination of surgery and chemotherapy and the role of targeted agents in the treatment of patients with colorectal liver metastases: Recommendations from an expert panel

Nordlinger, B., Van Cutsem, E., Gruenberger, T., Glimelius, B., Poston, G., Rougie, P., Sobrero, A. & Ychou, M., 2009, In : Annals of Oncology. 20, 6, p. 985-992 8 p.

Research output: Contribution to journalArticle

Evidence for cure by adjuvant therapy in colon cancer: Observations based on individual patient data from 20,898 patients on 18 randomized trials

Sargent, D., Sobrero, A., Grothey, A., O'Connell, M. J., Buyse, M., Andre, T., Zheng, Y., Green, E., Labianca, R., O'Callaghan, C., Seitz, J. F., Francini, G., Haller, D., Yothers, G., Goldberg, R. & De Gramont, A., Feb 20 2009, In : Journal of Clinical Oncology. 27, 6, p. 872-877 6 p.

Research output: Contribution to journalArticle

Highlights from the 2008 Gastrointestinal Cancers Symposium

Aprile, G. & Sobrero, A., Jan 2009, In : European Journal of Cancer Care. 18, 1, p. 10-17 8 p.

Research output: Contribution to journalArticle

Incremental advance or seismic shift? The need to raise the bar of efficacy for drug approval

Sobrero, A. & Bruzzi, P., Dec 10 2009, In : Journal of Clinical Oncology. 27, 35, p. 5868-5873 6 p.

Research output: Contribution to journalArticle

Medical oncology: IROX as second-line therapy for metastatic colorectal cancer

Sobrero, A., 2009, In : Nature Reviews Clinical Oncology. 6, 5, p. 248-250 3 p.

Research output: Contribution to journalArticle

Molecular markers of chemotherapy in advanced colorectal cancer: Back to square one

Sobrero, A., Jul 2009, In : European Journal of Cancer. 45, 11, p. 1902-1903 2 p.

Research output: Contribution to journalArticle

Randomized phase III trial comparing biweekly infusional fluorouracil/leucovorin alone or with irinotecan in the adjuvant treatment of stage III colon cancer: PETACC-3

Van Cutsem, E., Labianca, R., Bodoky, G., Barone, C., Aranda, E., Nordlinger, B., Topham, C., Tabernero, J., André, T., Sobrero, A. F., Mini, E., Greil, R., Di Costanzo, F., Collette, L., Cisar, L., Zhang, X., Khayat, D., Bokemeyer, C., Roth, A. D. & Cunningham, D., Jul 1 2009, In : Journal of Clinical Oncology. 27, 19, p. 3117-3125 9 p.

Research output: Contribution to journalArticle

The management of hepatocellular carcinoma. Current expert opinion and recommendations derived from the 10th World Congress on Gastrointestinal Cancer, Barcelona, 2008

Verslype, C., Van Cutsem, E., Dicato, M., Arber, N., Berlin, J. D., Cunningham, D., De Gramont, A., Diaz-Rubio, E., Ducreux, M., Gruenberger, T., Haller, D., Haustermans, K., Hoff, P., Kerr, D., Labianca, R., Moore, M., Nordlinger, B., Ohtsu, A., Rougier, P., Scheithauer, W. & 4 others, Schmoll, H. J., Sobrero, A., Tabernero, J. & van de Velde, C., 2009, In : Annals of Oncology. 20, SUPPL.7, p. 1-6 6 p.

Research output: Contribution to journalArticle

2008

A combination of gefitinib and FOLFOX-4 as first-line treatment in advanced colorectal cancer patients. A GISCAD multicentre phase II study including a biological analysis of EGFR overexpression, amplification and NF-kB activation

Cascinu, S., Berardi, R., Salvagni, S., Beretta, G. D., Catalano, V., Pucci, F., Sobrero, A., Tagliaferri, P., Labianca, R., Scartozzi, M., Crocicchio, F., Mari, E. & Ardizzoni, A., Jan 15 2008, In : British Journal of Cancer. 98, 1, p. 71-76 6 p.

Research output: Contribution to journalArticle

Capecitabine versus bolus fluorouracil plus leucovorin (folinic acid) as adjuvant chemotherapy for patients with Dukes' C colon cancer: Economic evaluation in an Italian NHS setting

Di Costanzo, F., Ravasio, R., Sobrero, A., Bertetto, O., Vinante, O., Luppi, G., Labianca, R., Amadori, D., Barone, C., Merlano, M. C., Longo, F., Mansueto, G., Antonuzzo, L. & Gasperoni, S., 2008, In : Clinical Drug Investigation. 28, 10, p. 645-655 11 p.

Research output: Contribution to journalArticle

Current challenges and future perspectives in the medical treatment of solid tumours

Sobrero, A. & Di Benedetto, M., Oct 2008, In : European Journal of Cancer, Supplement. 6, 14, p. 91-93 3 p.

Research output: Contribution to journalArticle

EPIC: Phase III trial of cetuximab plus irinotecan after fluoropyrimidine and oxaliplatin failure in patients with metastatic colorectal cancer

Sobrero, A. F., Maurel, J., Fehrenbacher, L., Scheithauer, W., Abubakr, Y. A., Lutz, M. P., Vega-Villegas, M. E., Eng, C., Steinhauer, E. U., Prausova, J., Lenz, H. J., Borg, C., Middleton, G., Kröning, H., Luppi, G., Kisker, O., Zubel, A., Langer, C., Kopit, J. & Burris, H. A., 2008, In : Journal of Clinical Oncology. 26, 14, p. 2311-2319 9 p.

Research output: Contribution to journalArticle

First-line single-agent cetuximab in patients with advanced colorectal cancer

Pessino, A., Artale, S., Sciallero, S., Guglielmi, A., Fornarini, G., Andreotti, I. C., Mammoliti, S., Comandini, D., Caprioni, F., Bennicelli, E., Andretta, V., Siena, S. & Sobrero, A., Apr 2008, In : Annals of Oncology. 19, 4, p. 711-716 6 p.

Research output: Contribution to journalArticle

Phase IV study of bevacizumab in combination with infusional fluorouracil, leucovorin and irinotecan (FOLFIRI) in First-line metastatic colorectal cancer

Sobrero, A., Ackland, S., Clarke, S., Perez-Carrión, R., Chiara, S., Gapski, J., Mainwaring, P., Langer, B. & Young, S., Aug 2008, In : Oncology. 77, 2, p. 113-119 7 p.

Research output: Contribution to journalArticle

Prevalence and treatment of cancer pain in Italian oncological wards centres: A cross-sectional survey

Mercadante, S., Roila, F., Berretto, O., Labianca, R., Casilini, S., Guido, B., Vittorio, T., Stefano, C., Francesco, D. V., Vito, L., Giuseppe, T., Luigi, E., Bruno, D., Andrea, M., Giovanni, M., Stefano, V., Sante, R., Giovanni, S., Giuseppe, S., Paolo, M. & 31 others, Stefano, M., Salvatore, P., Tullia, P., Carlo, M. M., Giuseppe, D. G., Dino, A., Alberto, S., Renato, A., Sergio, B., Ettore, G., Modesto, D., Chiara, F. R., Andrea, B., Enrico, A., Elena, P., Laura, P., Donata, T., Giacomo, C., Giuseppe, C., Oscar, A., Gennaro, L., Luigi, D., Nicola, G., Sergio, P., Gianfranco, F., Giuseppina, C., Raffaella, B., Sergio, R., Luigi, M., Carmelo, I. & Maurizio, M., Nov 2008, In : Supportive Care in Cancer. 16, 11, p. 1203-1211 9 p.

Research output: Contribution to journalArticle

Raltitrexed (Tomudex®) versus standard leucovorin-modulated bolus 5-fluorouracil: Results from the randomised phase III Pan-European Trial in Adjuvant Colon Cancer 01 (PETACC-1)

Popov, I., Carrato, A., Sobrero, A., Vincent, M., Kerr, D., Labianca, R., Raffaele Bianco, A., El-Serafi, M., Bedenne, L., Paillot, B., Mini, E., Sanches, E., Welch, J., Collette, L., Praet, M. & Wils, J., Oct 2008, In : European Journal of Cancer. 44, 15, p. 2204-2211 8 p.

Research output: Contribution to journalArticle

Small molecule inhibitors of tyrosine kinase: Waiting for the good news in colorectal cancer as well

Sobrero, A. & Andretta, V., May 2008, In : Onkologie. 31, 5, p. 224-225 2 p.

Research output: Contribution to journalArticle

The diagnosis and management of rectal cancer: Expert discussion and recommendations derived from the 9th world congress on gastrointestinal cancer, Barcelona, 2007

Van Cutsem, E., Dicato, M., Haustermans, K., Arber, N., Bosset, J. F., Cunningham, D., De Gramont, A., Diaz-Rubio, E., Ducreux, M., Goldberg, R., Glynne-Jones, R., Haller, D., Kang, Y. K., Kerr, D., Labianca, R., Minsky, B. D., Moore, M., Nordlinger, B., Rougier, P., Scheithauer, W. & 6 others, Schmoll, H. J., Sobrero, A., Tabernero, J., Tempero, M., Van de Velde, C. & Zalcberg, J., Jun 2008, In : Annals of Oncology. 19, SUPPL. 6

Research output: Contribution to journalArticle

Urgent need for a new staging system in advanced colorectal cancer

Poston, G. J., Figueras, J., Giuliante, F., Nuzzo, G., Sobrero, A. F., Gigot, J. F., Nordlinger, B., Adam, R., Gruenberger, T., Choti, M. A., Bilchik, A. J., Van Cutsem, E. J. D., Chiang, J. M. & D'Angelica, M. I., Oct 10 2008, In : Journal of Clinical Oncology. 26, 29, p. 4828-4833 6 p.

Research output: Contribution to journalArticle

2007

Correlation between variation in quality of life and change in hemoglobin level after treatment with epoetin alfa 40,000 IU administered once-weekly

Cartenì, G., Giannetta, L., Ucci, G., De Signoribus, G., Vecchione, A., Pinotti, G., Puglisi, F., Contillo, A., Pezzella, G., Orecchia, S., Beccaglia, P., Adamo, V., Aglietta, M., Alabiso, O., Altavilla, G., Amadori, D., Amunni, G., Bajetta, E., Bobbio Pallavicini, E., Bonsignori, M. & 54 others, Bordonaro, R., Bottini, A., Catalano, G., Chiavacci, A., Cigolari, S., Ciotti, R., Conte, P., Ricci, S., Contillo, A., Contu, A., Cortesi, E., Crispino, S., D'Aprile, M., De Chiara, A., De Signoribus, G., Del Prete, S., Donghi, M., Antonelli, P., Falcone, A., Fioretto, L., Fornasiero, A., Gamucci, T., Ghezzi, P., Giusto, M., Iacono, C., Lombardo, M., Manente, P., Mantovani, G., Marchetti, P., Masina, A., Mattioli, R., Menichetti, E., Minisini, A., Neri, B., Nettuno, R., Palazzo, S., Palmeri, S., Palmiotti, G., Patrone, F., Pezzella, G., Pinotti, G., Pizza, C., Pollera, F., Savarese, A., Savarino, A., Sbalzarini, G., Serravezza, G., Siena, S., Sobrero, A., Surace, G., Vecchione, A., Vietti Ramus, G., Vinante, O. & Zagonel, V., Sep 2007, In : Supportive Care in Cancer. 15, 9, p. 1057-1066 10 p.

Research output: Contribution to journalArticle

Does chemotherapy prior to liver resection increase the potential for cure in patients with metastatic colorectal cancer? A report from the European Colorectal Metastases Treatment Group

Nordlinger, B., Van Cutsem, E., Rougier, P., Köhne, C. H., Ychou, M., Sobrero, A., Adam, R., Arvidsson, D., Carrato, A., Georgoulias, V., Giuliante, F., Glimelius, B., Golling, M., Gruenberger, T., Tabernero, J., Wasan, H. & Poston, G., Sep 2007, In : European Journal of Cancer. 43, 14, p. 2037-2045 9 p.

Research output: Contribution to journalArticle

Endpoints in adjuvant treatment trials: A systematic review of the literature in colon cancer and proposed definitions for future trials

Punt, C. J. A., Buyse, M., Köhne, C. H., Hohenberger, P., Labianca, R., Schmoll, H. J., Påhlman, L., Sobrero, A. & Douillard, J. Y., Jul 4 2007, In : Journal of the National Cancer Institute. 99, 13, p. 998-1003 6 p.

Research output: Contribution to journalArticle

Epidermal growth factor receptor gene copy number and clinical outcome of metastatic colorectal cancer treated with panitumumab

Sartore-Bianchi, A., Moroni, M., Veronese, S., Carnaghi, C., Bajetta, E., Luppi, G., Sobrero, A., Barone, C., Cascinu, S., Colucci, G., Cortesi, E., Nichelatti, M., Gambacorta, M. & Siena, S., Aug 1 2007, In : Journal of Clinical Oncology. 25, 22, p. 3238-3245 8 p.

Research output: Contribution to journalArticle

Objectives of chemotherapy for unresectable liver metastases: Best response or resection?

Sobrero, A., De Cian, F., Andretta, V. & Pessino, A., Sep 2007, In : European Journal of Cancer, Supplement. 5, 5, p. 317-321 5 p.

Research output: Contribution to journalArticle